Sunday, December 17, 2017
Edited by: Jay Khapde, MD FAAEM and Michael C. Bond, MD FAAEM
Between the 2000 and 2010 U.S. Census, the population over age 65 increased at a higher rate that the overall U.S. population. For the purposes of this article, we will use age greater than 65 as the definition of a geriatric patient. By 2050, there will be over 83 million geriatric Americans, double the number from 2012.1 Currently, over 15% of emergency department (ED) visits, equaling 20 million total visits, are from geriatric patients.2 These numbers are certain to increase and will represent a unique challenge to the U.S. health care system, specifically to the ED. In this month’s “Resident Journal Review,” we focus on the evaluation, diagnosis, and treatment of geriatric patients presenting to the ED.
Thursday, December 14, 2017
Edited by: Jay Khadpe, MD FAAEM; Michael Bond, MD FAAEM
Originally Published: Common Sense January/February 2015
The emergency department (ED) is the most common place for treatment of anaphylaxis. While epinephrine is clearly indicated, the Emergency Medicine Practice Update Guidelines of 2011 state, “Despite a unified consensus around epinephrine as first-line treatment, patients are more likely to receive corticosteroids and antihistamines.” Prospective randomized controlled trials comparing medications for the treatment of anaphylaxis in humans are lacking, thus guidelines are based primarily on theory and anecdotal evidence. This summary examines various therapies and evaluates recommended ED observation times and dispositions.